Clinical trial
Posaconazole to Treat Invasive Fungal Infections
NCT00033982 · National Institute of Allergy and Infectious Diseases (NIAID), NIH · Completed
Key facts
| NCT number | NCT00033982 |
|---|---|
| Title | Posaconazole to Treat Invasive Fungal Infections |
| Official title | Open Label, Limited Access Protocol of Posaconazole in Invasive Fungal Infections |
| Lead sponsor | National Institute of Allergy and Infectious Diseases (NIAID), NIH |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Granulomatous Disease, Chronic, Job's Syndrome, Infection |
| Intervention type | Drug |
| Interventions | Posaconazole |
| Enrollment | 50 |
| Start date | Apr 11, 2002 |
| Completion | Feb 20, 2007 |
| First posted | Apr 19, 2002 |
| Last update posted | Jul 2, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: